Sep 9 - Sep 11, 2022Kyoto International Conference Center
[WFS-1]The progress of development of At-211 targeted alpha particle therapy at Fukushima Medical University and possibilities of combined therapy with external-beam radiation and immunotherapy
Shunichi Yamashita、Tohru Shiga、Koshin Washiyama、Kazuhiro Takahashi、Yoshiyuki Suzuki(Research Center, Fukushima medical university, Fukushima, Japan)
Password required to view
Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"